Results of a phase 3 study suggest that marstacimab reduces bleeding events in patients with hemophilia A and B and without safety concerns.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/marstacimab-cuts-bleeding-hemophilia-b-2025a1000sql?src=rss
Author :
Publish date : 2025-10-22 12:57:00
Copyright for syndicated content belongs to the linked Source.
